Biocompare.com RSS feed http://www.biocompare.com/ © 2010 Biocompare.com Sun, 01 Aug 2010 02:17:20 GMT http://backend.userland.com/rss RSS.NET: http://www.rssdotnet.com/ The apparently random self-assembly of molecular threads into the proteins that make the body work is far less frantic than previously thought, Michigan State University scientists say. That discovery could be a key to help unlock the nature of some diseases. http://news.biocompare.com/newsstory.asp?id=335977 Biocompare.com Fri, 30 Jul 2010 14:08:00 GMT The Food and Drug Administration (FDA) received reports of malignancies in children using tumor necrosis factor a (TNF) blockers, raising concerns of an associated risk and prompting an investigation. Researchers from the FDA set out to identify all reports of malignancy in children using infliximab, etanercept, and adalimumab and their report is published in the August issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology. http://news.biocompare.com/newsstory.asp?id=335976 Biocompare.com Fri, 30 Jul 2010 14:07:00 GMT CAMBRIDGE, Mass., July 29, 2010 -- Public immunization efforts may be much more sensitive than previously realized to small changes in the perceived costs or risks of vaccination, scientists at Harvard University report this week. In some cases, the spread of vaccine avoidance via social networks can make the difference between a minor, localized outbreak and an epidemic four times as large. http://news.biocompare.com/newsstory.asp?id=335961 Biocompare.com Fri, 30 Jul 2010 13:17:00 GMT Often causing no symptoms in carriers of the disease, worldwide tuberculosis (TB) infects eight to ten million people every year, kills two million, and it is highly contagious as it is spread through coughing and sneezing. "It's a global health disaster waiting to happen, even here in Canada, but this new paradigm in TB research may offer an immediate opportunity to improve vaccination and treatment initiatives," explains Dr. Maziar Divangahi of McGill University and of the Research Institute of the McGill University Health Centre. http://news.biocompare.com/newsstory.asp?id=335960 Biocompare.com Fri, 30 Jul 2010 13:14:00 GMT UCLA scientists have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and more effective targeted treatments for the disease. http://news.biocompare.com/newsstory.asp?id=335950 Biocompare.com Fri, 30 Jul 2010 12:05:00 GMT DNA Genotek, a leading provider of products for biological sample collection, stabilization and preparation, today announced that the world's leading TB vaccine research site, the South African Tuberculosis Vaccine Initiative (SATVI), has chosen Oragene.DNA for a study aimed at identifying host correlates of protection against TB, following BCG vaccination. http://news.biocompare.com/newsstory.asp?id=335938 Biocompare.com Fri, 30 Jul 2010 09:36:00 GMT Researchers in Heidelberg and Stanford have discovered a new signalling pathway of brain cells that explains how widely used antihypertensive drugs could keep inflammation in multiple sclerosis (MS) in check. The peptide angiotensin not only raises blood pressure but also activates the immunological messenger substance TGF beta on a previously unknown communication pathway in the brain. http://news.biocompare.com/newsstory.asp?id=335767 Biocompare.com Thu, 29 Jul 2010 15:32:00 GMT Drinking alcohol may reduce the severity of rheumatoid arthritis according to new research published today. It is the first time that this effect has been shown in humans. The study also finds that alcohol consumption reduces the risk of developing the disease, confirming the results of previous studies. http://news.biocompare.com/newsstory.asp?id=335542 Biocompare.com Wed, 28 Jul 2010 12:15:00 GMT Rogier van Doorn and colleagues from Ho Chi Minh city, Vietnam present a Learning Forum article in this week's PLoS Medicine that describes three unusual cases of patients with listerial meningitis. http://news.biocompare.com/newsstory.asp?id=335529 Biocompare.com Wed, 28 Jul 2010 11:32:00 GMT Novavax, Inc. announced today the issuance of U.S. Patent No. 7,763,450 for "Functional Influenza Virus-Like Particles (VLPS)". The patent covers the use of influenza gene sequences for high-yield production of consistent influenza VLP vaccines to protect against current and future seasonal and pandemic strains of influenza viruses. http://news.biocompare.com/newsstory.asp?id=335411 Biocompare.com Wed, 28 Jul 2010 04:00:00 GMT